litlas
Log inCreate account

Neil H. Segal

Active 2003–2025

Also published as
Neil H Segal
86
Papers
27,889
Citations
60
h-index
79
i10-index

Citations

Citations per year for Neil H. Segal1976: 1 citations1977: 1 citations2001: 1 citations2003: 5 citations2004: 30 citations2005: 40 citations2006: 34 citations2007: 41 citations2008: 36 citations2009: 51 citations2010: 47 citations2011: 39 citations2012: 36 citations2013: 82 citations2014: 226 citations2015: 319 citations2016: 302 citations2017: 336 citations2018: 354 citations2019: 1,026 citations2020: 1,495 citations2021: 1,494 citations2022: 1,233 citations2023: 1,059 citations2024: 1,492 citations2025: 766 citations2026: 11 citations1978–2000: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,995 citing papers, 27.5% of this breakdownChina: 2,403 citing papers, 16.6% of this breakdownItaly: 767 citing papers, 5.3% of this breakdownUnited Kingdom: 705 citing papers, 4.9% of this breakdownGermany: 670 citing papers, 4.6% of this breakdownFrance: 561 citing papers, 3.9% of this breakdownJapan: 482 citing papers, 3.3% of this breakdownSpain: 448 citing papers, 3.1% of this breakdownCanada: 405 citing papers, 2.8% of this breakdownNetherlands: 404 citing papers, 2.8% of this breakdownAustralia: 384 citing papers, 2.6% of this breakdownSwitzerland: 303 citing papers, 2.1% of this breakdown
0%27.5%Other 20.5%

Institutions

Fields

  • Medicine72.9%
  • Biochemistry, Genetics and Molecular Biology15%
  • Immunology and Microbiology9.4%
  • Engineering0.8%
  • Computer Science0.7%
  • Neuroscience0.3%
  • Other0.9%

Topics

  • Cancer Immunotherapy and Biomarkers17%
  • Immunotherapy and Immune Responses6.4%
  • CAR-T cell therapy research4.9%
  • Cancer Genomics and Diagnostics3.9%
  • Immune Cell Function and Interaction3.7%
  • Colorectal Cancer Treatments and Studies3.6%
  • Other60.5%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

    Authors: Andrea Cercek, Melissa Lumish, Jenna Sinopoli, Jill Weiss, Jinru Shia, Michelle F. Lamendola-Essel, Imane H. El Dika, Neil H. Segal, Marina Shcherba, Ryan Sugarman, Zsofia K. Stadler, Rona Yaeger, J. Joshua Smith, Benoı̂t Rousseau, Guillem Argilés, Mitesh Patel, Avni M. Desai, Leonard B. Saltz, Maria Widmar, Krishna Iyer, Janie Y. Zhang, Nicole Gianino, Christopher H. Crane, Paul B. Romesser, Emmanouil P. Pappou, Philip Paty, Julio García‐Aguilar, Mithat Gönen, Marc J. Gollub, Martin R. Weiser, Kurt A. Schalper, Luis A. Díaz - New England Journal of Medicine 2022 cited by 1,542

  3. Immunotherapy in colorectal cancer: rationale, challenges and potential

    Authors: Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek, Robin B. Mendelsohn, Jinru Shia, Neil H. Segal, Luis A. Díaz - Nature Reviews Gastroenterology & Hepatology 2019 cited by 2,019

  4. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

    Authors: Julio García‐Aguilar, Sujata Patil, Marc J. Gollub, Jin K. Kim, Jonathan B. Yuval, Hannah M. Thompson, Floris S. Verheij, Dana M. Omer, Meghan Lee, Richard F. Dunne, Jorge Marcet, Peter A. Cataldo, Blasé N. Polite, Daniel O. Herzig, David Liska, Samuel Oommen, Charles M. Friel, Charles A. Ternent, Andrew L. Coveler, Steven R. Hunt, Anita Gregory, Madhulika G. Varma, Brian L. Bello, Joseph C. Carmichael, John C. Krauss, Ana Gleisner, Philip B. Paty, Martin R. Weiser, Garrett M. Nash, Emmanouil P. Pappou, José G. Guillem, Larissa K. Temple, Iris H. Wei, Maria Widmar, Sabrina T. Lin, Neil H. Segal, Andrea Cercek, Rona Yaeger, J. Joshua Smith, Karyn A. Goodman, Abraham J. Wu, Leonard B. Saltz - Journal of Clinical Oncology 2022 cited by 906

  5. Nivolumab plus Ipilimumab in Advanced Melanoma

    Authors: Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan, Michael A. Postow, Naiyer A. Rizvi, Alexander M. Lesokhin, Neil H. Segal, Charlotte E. Ariyan, RuthAnn Gordon, Kathleen Reed, Matthew M. Burke, Anne Caldwell, Stephanie Anne Kronenberg, Blessing Agunwamba, Xiaoling Zhang, Israel Lowy, H. David Inzunza, William F. Feely, Christine E. Horak, Quan Hong, Alan J. Korman, Jon M. Wigginton, Ashok Gupta, Mario Sznol - New England Journal of Medicine 2013 cited by 4,221

  6. Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

    Authors: Jarushka Naidoo, Xuan Wang, Kaitlin M. Woo, Tunç Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E. Chaft, Neil H. Segal, Margaret K. Callahan, Alexander M. Lesokhin, Jonathan E. Rosenberg, Martin H. Voss, Charles M. Rudin, Hira Rizvi, Xue Hou, Katherine Rodríguez, Melanie Albano, Ruth-Ann Gordon, Charles Leduc, Natasha Rekhtman, Bianca Harris, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Benjamin Y. Kong, Jedd D. Wolchok, Michael A. Postow, Georgina V. Long, Matthew D. Hellmann - Journal of Clinical Oncology 2016 cited by 1,196

  7. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    Authors: Rona Yaeger, Walid K. Chatila, Marla Lipsyc, Jaclyn F. Hechtman, Andrea Cercek, Francisco Sánchez-Vega, Gowtham Jayakumaran, Sumit Middha, Ahmet Zehir, Mark T.A. Donoghue, Daoqi You, Agnès Viale, Nancy E. Kemeny, Neil H. Segal, Zsofia K. Stadler, Anna M. Varghese, Ritika Kundra, Jianjiong Gao, Aijazuddin Syed, David M. Hyman, Efsevia Vakiani, Neal Rosen, Barry S. Taylor, Marc Ladanyi, Michael F. Berger, David B. Solit, Jinru Shia, Leonard B. Saltz, Nikolaus Schultz - Cancer Cell 2018 cited by 864

  8. Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

    Authors: Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu, Shaad E. Abdullah, Brandon W. Higgs, Phillip A. Dennis, Michiel S. van der Heijden, Neil H. Segal, Jamie E. Chaft, Todd Hembrough, J. Carl Barrett, Matthew D. Hellmann - Cancer Discovery 2020 cited by 336

  9. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

    Authors: Floris S. Verheij, Dana M. Omer, Hannah Williams, Sabrina T. Lin, Li‐Xuan Qin, J. Thomas Buckley, Hannah M. Thompson, Jonathan B. Yuval, Jin K. Kim, Richard F. Dunne, Jorge Marcet, Peter A. Cataldo, Blasé N. Polite, Daniel O. Herzig, David Liska, Samuel Oommen, Charles M. Friel, Charles A. Ternent, Andrew L. Coveler, Steven R. Hunt, Anita Gregory, Madhulika G. Varma, Brian L. Bello, Joseph C. Carmichael, John C. Krauss, Ana Gleisner, José G. Guillem, Larissa K. Temple, Karyn A. Goodman, Neil H. Segal, Andrea Cercek, Rona Yaeger, Garrett M. Nash, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, Martin R. Weiser, Philip B. Paty, J. Joshua Smith, Abraham J. Wu, Marc J. Gollub, Leonard B. Saltz, Julio García‐Aguilar - Journal of Clinical Oncology 2023 cited by 321

  10. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    Authors: J. Joshua Smith, Paul Strombom, Oliver S. Chow, Campbell S.D. Roxburgh, Patricio B. Lynn, Anne Eaton, Maria Widmar, Karuna Ganesh, Rona Yaeger, Andrea Cercek, Martin R. Weiser, Garrett M. Nash, José G. Guillem, Larissa K. Temple, Sree B. Chalasani, James L. Fuqua, Iva Petkovska, Abraham J. Wu, Marsha Reyngold, Efsevia Vakiani, Jinru Shia, Neil H. Segal, James D. Smith, Christopher H. Crane, Marc J. Gollub, Mithat Gönen, Leonard B. Saltz, Julio García‐Aguilar, Philip B. Paty - JAMA Oncology 2019 cited by 594

  11. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

    Authors: Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argilés, Niall C. Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark Kozloff, Neil H. Segal, Alberto Sobrero, Yibing Yan, Ilsung Chang, Anne Uyei, Louise Roberts, Fortunato Ciardiello, JB Ahn, Jamil Asselah, Suprith Badarinath, Shobhit Baijal, S. Begbie, Sneha Berry, J. R. Canon, RG Carbone, Andrés Cervantes, YJ Cha, Karen Chang, Arvind Chaudhry, Ewa Chmielowska, Seung‐Hun Cho, Derek K. Chu, Félix Couture, Jennifer L. Cultrera, David Cunningham, Eric Van Cutsem, P-J. Cuyle, Janine M. Davies, Scot Dowden, Mikhail Dvorkin, Vinod Ganju, RV Garcia, Rachel Kerr, Tae‐Yop Kim, Kevin G. King, Jeremy Kortmansky, Mark Kozloff, Ko Lam, J Lee, AS Lee, Bernard Lespérance, Gabriele Luppi, Boyu Ma, Evaristo Maiello, Romeo A. Mandanas, J. L. Marshall, Gavin Marx, Saifee Mullamitha, Marina Nechaeva, Jo Park, Nick Pavlakis, CG Ponce, Piotr Potemski, Sherif Raouf, James A. Reeves, Neil H. Segal, Salvatore Siena, Alexey Smolin, JO Streb, A. H. Strickland, Ewa Szutowicz-Zielińska, Josep Tabernero, Benjamin Tan, JS Valera, Marc Van den Eynde, Philippe Vergauwe, Michael M. Vickers, Mark Womack, Marta Wróblewska, Ruth T. Young - The Lancet Oncology 2019 cited by 562

  12. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

    Authors: Alicia Latham, Preethi Srinivasan, Yelena Kemel, Jinru Shia, Chaitanya Bandlamudi, Diana Mandelker, Sumit Middha, Jaclyn F. Hechtman, Ahmet Zehir, Marianne Dubard-Gault, Christina Tran, Carolyn Stewart, Margaret Sheehan, Alexander Penson, Deborah F. DeLair, Rona Yaeger, Joseph Vijai, Semanti Mukherjee, Jesse Galle, Mark A. Dickson, Yelena Y. Janjigian, Eileen M. O’Reilly, Neil H. Segal, Leonard B. Saltz, Diane Reidy‐Lagunes, Anna M. Varghese, Dean F. Bajorin, Maria I. Carlo, Karen A. Cadoo, Michael F. Walsh, Martin R. Weiser, Julio García Aguilar, David S. Klimstra, Luis A. Díaz, José Baselga, Liying Zhang, Marc Ladanyi, David M. Hyman, David B. Solit, Mark E. Robson, Barry S. Taylor, Kenneth Offit, Michael F. Berger, Zsofia K. Stadler - Journal of Clinical Oncology 2018 cited by 627

  13. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Authors: Andrea Cercek, Campbell S.D. Roxburgh, Paul Strombom, J. Joshua Smith, Larissa K. Temple, Garrett M. Nash, José G. Guillem, Philip B. Paty, Rona Yaeger, Zsofia K. Stadler, Kenneth Seier, Mithat Gönen, Neil H. Segal, Diane Reidy‐Lagunes, Anna M. Varghese, Jinru Shia, Efsevia Vakiani, Abraham J. Wu, Christopher H. Crane, Marc J. Gollub, Julio García‐Aguilar, Leonard B. Saltz, Martin R. Weiser - JAMA Oncology 2018 cited by 645

  14. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

    Authors: Andrea Cercek, Walid K. Chatila, Rona Yaeger, Henry Walch, Gustavo dos Santos Fernandes, Asha Krishnan, Lerie Palmaira, Anna Maio, Yelena Kemel, Preethi Srinivasan, Chaitanya Bandlamudi, Erin Salo‐Mullen, Prince Ray Tejada, Kimeisha Belanfanti, Jesse Galle, Joseph Vijai, Neil H. Segal, Anna M. Varghese, Diane Reidy‐Lagunes, Jinru Shia, Efsevia Vakiani, Sebastián Mondaca, Robin B. Mendelsohn, Melissa Lumish, Felix Steinruecke, Nancy E. Kemeny, Louise C. Connell, Karuna Ganesh, Arnold J. Markowitz, Garrett M. Nash, José G. Guillem, J. Joshua Smith, Phillip Paty, Liying Zhang, Diana Mandelker, Ozge Ceyhan‐Birsoy, Mark E. Robson, Kenneth Offit, Barry S. Taylor, Michael F. Berger, David B. Solit, Martin R. Weiser, Leonard B. Saltz, Julio García‐Aguilar, Nikolaus Schultz, Luis A. Díaz, Zsofia K. Stadler - JNCI Journal of the National Cancer Institute 2021 cited by 195

  15. Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody

    Authors: Neil H. Segal, Theodore F. Logan, F. Stephen Hodi, David F. McDermott, Ignacio Melero, Omid Hamid, Henrik Schmidt, Caroline Robert, Vanna Chiarion‐Sileni, Paolo A. Ascierto, Michele Maio, Walter J. Urba, Tara C. Gangadhar, Satyendra Suryawanshi, Jaclyn Neely, Maria Jure–Kunkel, Suba Krishnan, Holbrook E. Kohrt, Mario Sznol, Ronald Levy - Clinical Cancer Research 2016 cited by 412

  16. Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

    Authors: Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih, Apostolia M. Tsimberidou, Joseph E. Grossman, Michael S. Gordon, Breelyn A. Wilky, Agustin Pimentel, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Ghassan K. Abou‐Alfa, Neil H Segal, Bruno Bockorny, Justin C. Moser, Sunil Sharma, Jaymin Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloé Delépine, Tyler J. Curiel, Justin Stebbing, Heinz‐Josef Lenz, Steven O’Day, Anthony B. El-Khoueiry - Nature Medicine 2024 cited by 110

  17. Mismatch Repair–Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

    Authors: Andrea Cercek, Gustavo dos Santos Fernandes, Campbell S.D. Roxburgh, Karuna Ganesh, Shu Ng, Francisco Sánchez-Vega, Rona Yaeger, Neil H. Segal, Diane Reidy‐Lagunes, Anna M. Varghese, Arnold J. Markowitz, Chao Wu, Bryan Szeglin, Charles-Etienne Gabriel Sauvé, Erin Salo‐Mullen, Christina Tran, Zalak Patel, Asha Krishnan, Kaitlyn Tkachuk, Garrett M. Nash, José G. Guillem, Philip B. Paty, Jinru Shia, Nikolaus Schultz, Julio García‐Aguilar, Luis A. Díaz, Karyn A. Goodman, Leonard B. Saltz, Martin R. Weiser, J. Joshua Smith, Zsofia K. Stadler - Clinical Cancer Research 2020 cited by 247

  18. PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

    Authors: Benoit Rousseau, Ivan Bieche, Eric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon, Aurelien de Reynies, Valerie Attignon, Michael B. Foote, Julien Masliah-Planchon, Magali Svrcek, Romain Cohen, Victor Simmet, Paule Augereau, David Malka, Antoine Hollebecque, Damien Pouessel, Carlos Gomez-Roca, Rosine Guimbaud, Amandine Bruyas, Marielle Guillet, Jean-Jacques Grob, Muriel Duluc, Sophie Cousin, Christelle de la Fouchardiere, Aude Flechon, Frederic Rolland, Sandrine Hiret, Esma Saada-Bouzid, Olivier Bouche, Thierry Andre, Diane Pannier, Farid El Hajbi, Stephane Oudard, Christophe Tournigand, Jean-Charles Soria, Stephane Champiat, Drew G. Gerber, Dennis Stephens, Michelle F. Lamendola-Essel, Steven B. Maron, Bill H. Diplas, Guillem Argiles, Asha R. Krishnan, Severine Tabone-Eglinger, Anthony Ferrari, Neil H. Segal, Andrea Cercek, Natalie Hoog-Labouret, Frederic Legrand, Clotilde Simon, Assia Lamrani-Ghaouti, Luis A. Diaz, Pierre Saintigny, Sylvie Chevret, Aurelien Marabelle - Cancer Discovery 2022 cited by 77

  19. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

    Authors: Viswanath Reddy Belum, Benjamin Benhuri, Michael A. Postow, Matthew D. Hellmann, Alexander M. Lesokhin, Neil H. Segal, Robert J. Motzer, Shenhong Wu, Klaus J. Busam, Jedd D. Wolchok, Mario E. Lacouture - European Journal of Cancer 2016 cited by 415

  20. Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

    Authors: Neil H. Segal, Aiwu Ruth He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari, Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, Ajay K. Gopal - Clinical Cancer Research 2018 cited by 279

  21. Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

    Authors: Christophe Massard, Michael S. Gordon, Sunil Sharma, Saeed Rafii, Zev A. Wainberg, Jason J. Luke, Tyler J. Curiel, Gerardo Colón‐Otero, Omid Hamid, Rachel E. Sanborn, Peter H. O’Donnell, Alexandra Drakaki, Winston Tan, John F. Kurland, Marlon C. Rebelatto, Xiaoping Jin, John A. Blake-Haskins, Ashok Gupta, Neil H. Segal - Journal of Clinical Oncology 2016 cited by 845

  22. Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment

    Authors: Atthaphorn Trakarnsanga, Mithat Gönen, Jinru Shia, Garrett M. Nash, Larissa K. Temple, José G. Guillem, Philip B. Paty, Karyn A. Goodman, Abraham J. Wu, Marc J. Gollub, Neil H. Segal, Leonard B. Saltz, Julio García‐Aguilar, Martin R. Weiser - JNCI Journal of the National Cancer Institute 2014 cited by 267

  23. Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

    Authors: Neil H. Segal, Andrea Cercek, Geoffrey Y. Ku, Abraham J. Wu, Andreas Rimner, Danny N. Khalil, Diane Reidy‐Lagunes, John Cuaron, Jonathan T. Yang, Martin R. Weiser, Paul B. Romesser, Zsofia K. Stadler, Anna M. Varghese, Karuna Ganesh, Rona Yaeger, Louise C. Connell, David M. Faleck, Ghassan K. Abou‐Alfa, Kathleen C. Mcauliffe, Pamela Vaiskauskas, Mark L. Solter, Martinique Ogle, Matthew Adamow, Aliya Holland, Pallavi Vedantam, Phillip Wong, Taha Merghoub, Efsevia Vakiani, Travis J. Hollmann, Krishna Juluru, Joanne F. Chou, Marinela Capanu, Joseph P. Erinjeri, Stephen B. Solomon, Yoshiya Yamada, Nancy E. Kemeny, Christopher H. Crane, Leonard B. Saltz - Clinical Cancer Research 2021 cited by 86

  24. Epitope Landscape in Breast and Colorectal Cancer

    Authors: Neil H. Segal, D. Williams Parsons, Karl S. Peggs, Victor E. Velculescu, Ken W Kinzler, Bert Vogelstein, James P. Allison - Cancer Research 2008 cited by 415